Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000243319 | SCV000310099 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000405260 | SCV000365655 | benign | Generalized juvenile polyposis/juvenile polyposis coli | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV001689844 | SCV000602642 | benign | not provided | 2021-07-12 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000580246 | SCV000682858 | benign | Hereditary cancer-predisposing syndrome | 2016-03-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000405260 | SCV001775016 | benign | Generalized juvenile polyposis/juvenile polyposis coli | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001689844 | SCV001914911 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002058150 | SCV002458393 | benign | Juvenile polyposis syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV002058150 | SCV004016724 | benign | Juvenile polyposis syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001689844 | SCV005317635 | benign | not provided | criteria provided, single submitter | not provided | ||
Myriad Genetics, |
RCV002058150 | SCV005404053 | benign | Juvenile polyposis syndrome | 2024-08-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Mayo Clinic Laboratories, |
RCV000243319 | SCV000691804 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000243319 | SCV001925370 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000243319 | SCV001959934 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000243319 | SCV001973867 | benign | not specified | no assertion criteria provided | clinical testing |